CMS expands state waiver rules for account-based approach

States will have more flexibility to introduce new healthcare options to residents under a new policy from CMS that impacts waivers.

The options, which the agency has said are “alternatives to the Affordable Care Act (ACA) that improve health insurance options,” allow states to divert funds toward a health savings account-based approach and three other waiver concepts.

“Seeing the problems the ACA created and seeing the lack of federal action to address these problems should be proof enough for why it was such a mistake to federalize so much of health care policy under the ACA,” CMS Administrator Seema Verma said in a statement.

The initiative specifically takes aim at section 1332 waivers, which the agency calls State Relief and Empowerment Waivers. The policy also allows states to divert subsidies toward plans that do not meet ACA guidelines, including short-term healthcare plans, which often aren’t comprehensive but come at a lower cost. The plans have come under fire by some lawmakers who call them “junk insurance.”

CMS previously issued a guidance on the initiative and expanded permissible 1332 waivers in October. Under the latest waiver change, states could make a contribution to accounts to subsidize healthcare expenses, similar to a health savings plan.

“The account-based approach would allow a state to provide a cash contribution to an account that people can use to pay both premiums and any out-of-pocket health expenses,” the announcement reads.

In addition to the account-based approach, CMS will allow states to apply for waivers to:

  • Develop a new premium subsidy structure and decide how those premiums should be targeted.
  • Set the rule for what type of health plan is eligible for state premium subsidies.
  • Implement risk stabilization strategies to address the costs of high-risk individuals.

Read the policy here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.